Homozygous Familial Hypercholesterolemia (HoFH) Latest Advances

Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent.

Journal: Current opinion in lipidology

Published: November 05, 2025

Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.

Journal: Journal of tropical pediatrics

Published: October 29, 2025

Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study.

Journal: Journal of clinical medicine

Published: October 12, 2025

Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.

Journal: JACC. Case reports

Published: October 10, 2025

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Journal: Journal of atherosclerosis and thrombosis

Published: October 08, 2025

Clinical features of familial hypercholesterolemia in children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: September 17, 2025

Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia.

Journal: Journal of medicinal chemistry

Published: September 16, 2025

An overview of familial hypercholesterolemia in children and adolescents. The story so far.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: September 09, 2025

Achieving the impossible: effective reduction of low-density lipoprotein cholesterol (LDL-C) in a patient with homozygous familial hypercholesterolemia.

Journal: Endokrynologia Polska

Published: September 04, 2025

A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia.

Journal: Medical research archives

Published: September 02, 2025

Effects of evinacumab on high-density lipoprotein function in patients with homozygous familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: August 25, 2025

Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report.

Journal: Journal of atherosclerosis and thrombosis

Published: August 13, 2025

Filters

Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent.

Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent.

Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.

Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.

Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study.

Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study.

Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.

Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Clinical features of familial hypercholesterolemia in children

Clinical features of familial hypercholesterolemia in children

Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia.

Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia.

An overview of familial hypercholesterolemia in children and adolescents. The story so far.

An overview of familial hypercholesterolemia in children and adolescents. The story so far.

Achieving the impossible: effective reduction of low-density lipoprotein cholesterol (LDL-C) in a patient with homozygous familial hypercholesterolemia.

Achieving the impossible: effective reduction of low-density lipoprotein cholesterol (LDL-C) in a patient with homozygous familial hypercholesterolemia.

A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia.

A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia.

Effects of evinacumab on high-density lipoprotein function in patients with homozygous familial hypercholesterolemia.

Effects of evinacumab on high-density lipoprotein function in patients with homozygous familial hypercholesterolemia.

Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report.

Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report.